The NavDx test is the first and most clinically validated liquid biopsy test for early detection of HPV+ cancer recurrence.
Waltham, MA
- Tweets 378
- Following 198
- Followers 282
- Likes 14
The NavDx test is the first and most clinically validated liquid biopsy test for early detection of HPV+ cancer recurrence.
